Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care

    July 2023 in “ Hypertension ”
    Noha M. Shawky, Jane F. Reckelhoff, Barbara T. Alexander, Licy L. Yanes Cardozo
    Studysummary This review highlights the association between gender-affirming hormone therapy and increased cardiovascular risk among transgender individuals, emphasizing the need for cardiovascular-focused clinical management and further research to inform and educate both clinicians and patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pmc.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study Journal of the American Heart Association · 2022
    2. Serum Androgens and Risk of Atrial Fibrillation in Older Men: The Cardiovascular Health Study Clinical cardiology · 2018
    3. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology & Metabolism · 2017
    4. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 ˜The œinternational journal of transgenderism/International journal of transgenderism · 2012
    5. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006

    Related research 1

    1. Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents Adolescent Health, Medicine and Therapeutics · 2022